Notice of Interim Results
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your SCLP notes
Scancell Holdings plc (AIM: SCLP), a clinical-stage biopharmaceutical company developing novel immunotherapies for cancer, will announce its interim results for the six months ended 31 October 2024 on Thursday 30 January 2025.
Dr Phil L'Huillier, Chief Executive Officer, and Sath Nirmalananthan, Chief Financial Officer, will host a virtual analyst briefing at 14:00 GMT on the day of the results. There will also be a live webcast and conference call with a Q&A session, which can be accessed via this link: https://www.lsegissuerservices.com/spark/ScancellHoldings/events/ed5646ee-d413-404a-8a95-73bfef540393.
A copy of the presentation and webcast will be shared on the Investor Relations section of the Company's website at https://scancell.co.uk/ shortly afterwards.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.